FDA Approves First-in-Class Drug for HIV FDA Approves First-in-Class Drug for HIV

After the initiation dose, lenacapavir is administered subcutaneously every 6 months.Medscape Medical News
Source: Medscape Hiv-Aids Headlines - Category: Infectious Diseases Tags: HIV/AIDS News Alert Source Type: news